Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing Cohort Interim Data from Atopic Dermatitis Trial Expected to be Announced December 2024 Registration Phase 3 ...
Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback